Nicholas Buss is an experienced leader in translational sciences, currently serving as Associate Vice President at Eli Lilly and Company since 2023. Previously, they held the position of Vice President of Translational Research at Akouos and served as Associate Director at MedImmune from 2011 to 2018. Nicholas's earlier roles include Senior Director at REGENXBIO Inc. and various positions in safety assessment at GlaxoSmithKline. They earned a BSc (Hons) in Applied Biology from Brunel University and a PhD in Stress and Inflammation from Imperial College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices